Guidant CEO Dollens Named To HHS Secretary’s Regulatory Reform Panel

Guidant President and CEO Ronald Dollens is part of a 27-member panel appointed by HHS Secretary Tommy Thompson to consider ways to reduce administrative burdens at FDA and the Centers for Medicare & Medicaid Services